scholarly article | Q13442814 |
P50 | author | Patricia C Harkness | Q125912866 |
P2093 | author name string | Neil S Millar | |
P2860 | cites work | Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study | Q27867696 |
Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially | Q28260715 | ||
Ion-channel assembly | Q28290120 | ||
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment | Q28324465 | ||
Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel | Q33267111 | ||
Purification and characterization of a nicotinic acetylcholine receptor from rat brain | Q34590715 | ||
Host cell-specific folding of the neuronal nicotinic receptor alpha8 subunit | Q38337270 | ||
Inefficient cell-surface expression of hybrid complexes formed by the co-assembly of neuronal nicotinic acetylcholine receptor and serotonin receptor subunits | Q40793688 | ||
Multistep expression and assembly of neuronal nicotinic receptors is both host-cell- and receptor-subtype-dependent | Q40898571 | ||
Up-regulation of cell-surface alpha4beta2 neuronal nicotinic receptors by lower temperature and expression of chimeric subunits | Q40929948 | ||
Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells | Q41000471 | ||
Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition | Q41032740 | ||
Differences in the fate of neuronal acetylcholine receptor protein expressed in neurons and stably transfected cells | Q41075732 | ||
Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. | Q41113796 | ||
Host cell-specific folding and assembly of the neuronal nicotinic acetylcholine receptor alpha7 subunit | Q41114631 | ||
Temperature-sensitive expression of Drosophila neuronal nicotinic acetylcholine receptors | Q41114667 | ||
Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell line | Q41250813 | ||
Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. | Q41280354 | ||
Regulation of alpha 4 beta 2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. | Q41379239 | ||
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. | Q41444826 | ||
Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts | Q41663619 | ||
Ion channel assembly: creating structures that function | Q41911011 | ||
Determinants responsible for assembly of the nicotinic acetylcholine receptor | Q41911016 | ||
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor | Q42557583 | ||
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment | Q43522413 | ||
Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies | Q44614400 | ||
Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors | Q46230361 | ||
The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity | Q47072355 | ||
Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment. | Q47723489 | ||
Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain | Q48092964 | ||
Antibodies against the extracellular domain of the 5-HT3 receptor label both native and recombinant receptors | Q48227914 | ||
Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system | Q48347633 | ||
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors | Q48430108 | ||
In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs | Q48465597 | ||
Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways | Q48632013 | ||
Contributions of N-linked glycosylation to the expression of a functional alpha7-nicotinic receptor in Xenopus oocytes | Q48948173 | ||
Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities | Q49124973 | ||
Neuronal alpha-bungarotoxin receptors differ structurally from other nicotinic acetylcholine receptors. | Q52559453 | ||
Functional properties of neuronal nicotinic acetylcholine receptor channels expressed in transfected human cells. | Q53972741 | ||
Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells | Q74509772 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10172-10181 | |
P577 | publication date | 2002-12-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras | |
P478 | volume | 22 |
Q33853977 | A nicotinic acetylcholine receptor mutation conferring target-site resistance to imidacloprid in Nilaparvata lugens (brown planthopper). |
Q45159526 | Alpha7 but not alpha4 AChR subunit expression is regulated by light in developing primary visual cortex. |
Q34197378 | Cell Surface Expression of 5-Hydroxytryptamine Type 3 Receptors Is Controlled by an Endoplasmic Reticulum Retention Signal |
Q42173324 | Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation |
Q33924248 | Choline promotes nicotinic receptor alpha4 + beta2 up-regulation |
Q36465049 | Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism |
Q37454529 | Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. |
Q34130786 | Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention |
Q37664769 | Differential Contribution of Subunit Interfaces to α9α10 Nicotinic Acetylcholine Receptor Function |
Q38950808 | Examination of the Involvement of Cholinergic-Associated Genes in Nicotine Behaviors in European and African Americans |
Q36274171 | Exposure to nicotine and sensitization of nicotine-induced behaviors |
Q30432387 | Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways |
Q48439102 | Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. |
Q37629259 | Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications |
Q40354072 | Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells |
Q24672543 | Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells |
Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
Q37196810 | Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons |
Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
Q37690295 | Neurotransmitter receptors as central regulators of pancreatic cancer |
Q34439566 | Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning |
Q34211873 | Nicotine-induced up regulation of α4β2 neuronal nicotinic receptors is mediated by the protein kinase c-dependent phosphorylation of α4 subunits |
Q35777580 | Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms |
Q37525085 | Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction |
Q37760463 | Nicotine: alcohol reward interactions |
Q30430585 | Nicotinic acetylcholine receptor alpha7 subunits with a C2 cytoplasmic loop yellow fluorescent protein insertion form functional receptors |
Q26782271 | Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use |
Q38472884 | Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach |
Q34668336 | RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation |
Q37075854 | RIC-3: a nicotinic acetylcholine receptor chaperone |
Q37603902 | Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors. |
Q42972130 | Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release |
Q28580629 | Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regions |
Q44618363 | Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography |
Q43146798 | The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix |
Q34919642 | bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse |
Q33551855 | beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking |
Search more.